Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

3.38
Delayed Data
As of Jun 23
 +0.07 / +2.11%
Today’s Change
1.57
Today|||52-Week Range
4.77
+78.84%
Year-to-Date

Today’s Trading

Previous close3.31
Today’s open3.37
Day’s range3.37 - 3.80
Volume160,099
Average volume (3 months)78,149
Market cap$49.7M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+54.12%
Earnings growth (this year)-31.90%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-27.85%
P/E ratioNM
Price/Sales77.98
Price/Book6.31

Competitors

 Today’s
change
Today’s
% change
SCYXSCYNEXIS Inc-0.01-0.52%
PULMPulmatrix Inc+0.15+6.02%
ITEKInotek Pharmaceutica...-0.10-5.26%
RGLSRegulus Therapeutics...-0.07-7.58%
Data as of 3:59pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$355.0K
Annual profit (last year)-$15.3M
Net profit margin-4,307.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maslowski
Controller, Chief Financial &
Accounting Officer
Lisa A. Embon
Corporate headquarters
Exton, Pennsylvania

Forecasts